Quest Diagnostics Incorporated Common Stock (DGX)
Healthcare › Services-Medical Laboratories
Price History
Feb 9, 2026 — Aug 9, 2026Investment Snapshot
- Trading 93% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- ROE of 14.6% — below-average profitability
- Revenue growing at 12% annually
Quest Diagnostics Incorporated Common Stock (DGX) is a Healthcare company operating in Services-Medical Laboratories, listed on the NYSE , with a market capitalisation of $26.3 billion . Key value metrics: P/E ratio 23.9, P/B ratio 3.50, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Quest Diagnostics Incorporated Common Stock — Fundamental Analysis Summary
Quest Diagnostics Incorporated Common Stock (DGX) is currently trading 93% above its Graham Number of $123.51, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 23.9x.
On financial health, DGX shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 14.6% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.75.
StockPik's composite Value Score for DGX is 67/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
DGX reports a moderate gross margin of 33.5% (sector average: 37.4%) and a solid operating margin of 14.6%.
DGX shows revenue growing at 12% year-over-year, with earnings growing at 14%.
DGX pays a modest dividend yield of 1.4%.